Relmada Therapeutics (RLMD) EPS (Diluted) (2014 - 2026)
Powered by 
Analysis
Relmada Therapeutics (RLMD) EPS (Diluted) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.15 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | -0.11 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.21 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.58 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.73 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -0.85 |
| Sep 30, 2023 | -0.71 |
| Jun 30, 2023 | -0.82 |
| Mar 31, 2023 | -0.90 |
| Dec 31, 2022 | -1.31 |
| Sep 30, 2022 | -1.29 |
| Jun 30, 2022 | -1.52 |
| Mar 31, 2022 | -1.35 |
| Dec 31, 2021 | -1.95 |
| Sep 30, 2021 | -2.44 |